SURFACE ARRAYED THERAPEUTICS Trademark

Trademark Overview

On Monday, April 11, 2016, a trademark application was filed for SURFACE ARRAYED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SURFACE ARRAYED THERAPEUTICS trademark a serial number of 86970783. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 15, 2024. This trademark is owned by Particle Sciences, Inc.. The SURFACE ARRAYED THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research services; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development
surface arrayed therapeutics

General Information

Serial Number86970783
Word MarkSURFACE ARRAYED THERAPEUTICS
Filing DateMonday, April 11, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 15, 2024
Registration Number5277372
Registration DateTuesday, August 29, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2016

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical research services; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 15, 2024
Primary Code042
First Use Anywhere DateFriday, March 31, 2017
First Use In Commerce DateFriday, March 31, 2017

Trademark Owner History

Party NameParticle Sciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBethlehem, PA 18017
Party NameParticle Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethlehem, PA 18017
Party NameParticle Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethlehem, PA 18017

Trademark Events

Event DateEvent Description
Friday, March 15, 2024CANCELLED SEC. 8 (6-YR)
Monday, August 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 29, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 29, 2017REGISTERED-PRINCIPAL REGISTER
Friday, July 28, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 27, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 26, 2017ASSIGNED TO EXAMINER
Monday, May 22, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, April 28, 2017USE AMENDMENT FILED
Monday, May 22, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 28, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, November 15, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 17, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, August 13, 2016ASSIGNED TO LIE
Wednesday, August 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 1, 2016NON-FINAL ACTION E-MAILED
Monday, August 1, 2016NON-FINAL ACTION WRITTEN
Tuesday, July 26, 2016ASSIGNED TO EXAMINER
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2016NEW APPLICATION ENTERED

Related Keywords

therapeutics arrayed surface pharmaceutical services development research field drug consulting